Rise in Demand spooks DEA - officials talking of Epidemic

During COVID, there was a significant increase in ADHD diagnoses due to the DEA's relaxation of rules around telehealth prescriptions. Despite this, the DEA did not increase its production quotas, leading to a surge in demand without a corresponding rise in supply. Consequently, the DEA is now concerned about a potential drug epidemic similar to the opioid crisis, particularly regarding Adderall. This situation raises questions about the DEA's quotas and the potential risks of Adderall overdose, although specific cases of overdose related to Adderall are not readily available. Moreover, the main side effect of abusing prescription stimulants seems to be obtaining a college degree.